NASDAQ: AERI - Aerie Pharmaceuticals

Yield per half year: 0%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Aerie Pharmaceuticals

Extended chart Simple chart
Financial Markets by TradingView

About Aerie Pharmaceuticals

Aerie Pharmaceuticals Inc. (Nasdaq: AERI) - публичная фармацевтическая компания клинической стадии, деятельность которой направлена на открытие, разработку и коммерциализацию первоклассных методов лечения пациентов с глаукомой и другими заболеваниями глаз. Два основных продукта-кандидата от Aerie - это препараты для снижения ВГД с новыми механизмами действия один раз в день для лечения пациентов с глаукомой или глазной гипертензией.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2013-10-25
ISIN US00771V1089
Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.aeriepharma.com
Цена ао 15.2
Change price per day: 0% (15.25)
Change price per week: 0% (15.25)
Change price per month: 0% (15.25)
Change price per 3 month: 0% (15.25)
Change price per half year: 0% (15.25)
Change price per year: 0% (15.25)
Change price per 3 year: +61.38% (9.45)
Change price per 5 year: +32.72% (11.49)
Change price per 10 year: -34.18% (23.17)
Change price per year to date: 0% (15.25)
All parameters

Underestimation

Title Value Grade
P/S 3.38 5
P/BV 33.5 1
P/E 0 0
EV/EBITDA -92.03 0
Total: 2.25

Efficiency

Title Value Grade
ROA, % -9.06 0
ROE, % 40.32 10
Total: 1.67

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -108.71 10
Total: 7.8

Growth impulse

Title Value Grade
Yield Revenue, % 783.88 10
Yield Ebitda, % -98.64 0
Yield EPS, % -86.3 0
Total: 2
More

Institutions Volume Share, %
Deerfield Management Company, L.P. (Series C) 4695020 9.5
Blackrock Inc. 3431770 6.94
Vanguard Group, Inc. (The) 2719487 5.5
Bank of America Corporation 2599748 5.26
Jefferies Group LLC 2361000 4.78
Schroder Investment Management Group 2094811 4.24
Morgan Stanley 1991084 4.03
UBS Group AG 1710637 3.46
Rice, Hall, James & Associates 1603458 3.24
Ameriprise Financial, Inc. 1419176 2.87



Head Job title Payment Year of birth
Mr. John W. LaRocca Esq. Gen. Counsel & Sec. 676.62k 1965 (60 years)
Ms. Carolyn McAuliffe Sr. Director of Communications N/A
Mr. Raj Kannan CEO, Principal Financial Officer & Director 753.49k 1964 (61 year)
Dr. Casey C. Kopczynski Ph.D. Co-Founder, Chief Innovation Officer & Head of Research and External Innovation 685.06k 1961 (64 years)
Mr. Peter F. Lang Chief Financial Officer N/A 1972 (53 years)
Dr. Michelle Senchyna Ph.D. Head of Clinical Devel. & Operations N/A
Mr. Jeffrey M. Calabrese CPA VP of Fin. & Principal Accounting Officer N/A 1967 (58 years)
Ms. Wanda Francies Head of HR N/A
Mr. Marvin J. Garrett Head of Regulatory Affairs & Quality Assurance N/A 1951 (74 years)
Mr. Craig R. Skenes Head of Bus. Devel. N/A

Address: United States, Durham, NC , 4301 Emperor Boulevard - open in Google maps, open in Yandex maps
Website: http://www.aeriepharma.com